About Leupro Tech 11.25mg - Leuprolide Acetate Injection
Background and Date of approval LEUPROLIDE ACETATE
Leuprolide Acetate is a gonadotropin-releasing hormone (GnRH) agonist approved for its medical use on 9th April 1985.
Uses of LEUPROLIDE ACETATE
Leuprolide Acetate Injection has been developed to treat solid tumors by injecting it directly into the bloodstream. Leuprolide Acetate Injection has been approved to treat several conditions such as prostate cancer, endometriosis, uterine fibroids and other hormonal conditions.
How is LEUPROLIDE ACETATE administered?
Leuprolide acetate Injection is available in different doses. This injection will be mostly administered by your doctor or nurse on your arm, thigh or abdomen after preparation. The site of injecting this medicine will be changed regularly. Your healthcare provider will administer this medicine once in three months.
Side Effects of LEUPROLIDE ACETATE
The common side effects that are likely to occur while you are on the treatment with Leuprolide Acetate Injection are hot flashes, headache, vaginal inflammation for women, depression, weight loss/gain, pain, nausea, vomiting, low libido and dizziness. If you experience any reactions such as excessive sweating, breathlessness, severe headache, report to your doctor immediately.
Extended Action Hormone TherapyLeupro Tech 11.25mg offers a 3-month depot formulation, meaning one injection can provide sustained hormone suppression for up to three months. This long-acting effect helps in reducing the frequency of injections and supports consistent therapeutic outcomes in hormone-sensitive cancers and gynecological conditions.
Secure and Convenient PackagingEach kit is individually packaged, sterile, and contains all necessary components for safe preparation and administration, including a lyophilized powder vial, sterile diluent, needles, and an alcohol swab. This design ensures the integrity of the medication and reduces the risk of contamination.
FAQ's of Leupro Tech 11.25mg - Leuprolide Acetate Injection:
Q: How should Leupro Tech 11.25mg be administered?
A: Leupro Tech 11.25mg should be administered by a healthcare professional either intramuscularly or subcutaneously. The lyophilized powder must be reconstituted with the provided sterile diluent before injection. Always follow your physician's precise instructions for preparation and administration.
Q: What conditions is Leupro Tech 11.25mg used to treat?
A: This injection is indicated for hormone-sensitive cancers such as prostate cancer, as well as gynecological conditions like endometriosis, uterine fibroids, and central precocious puberty. Your doctor will determine if this medication is appropriate for your condition.
Q: When should the injection be used, and how often is it administered?
A: Leupro Tech 11.25mg is designed as a 3-month depot, meaning one injection provides hormone suppression for up to three months. Scheduling and usage depend on the doctor's guidance based on your treatment plan and therapeutic response.
Q: Where should Leupro Tech 11.25mg be stored?
A: Store Leupro Tech 11.25mg below 25C and protect it from light. It must remain in its original packaging until ready for use. Proper storage maintains the medication's sterility and potency.
Q: What are the steps for preparing the injection?
A: For preparation, combine the lyophilized powder with the provided sterile diluent using aseptic technique. The reconstituted solution must be used immediately and should not be mixed with any other medications. Be sure to follow your healthcare provider's instructions during the process.
Q: What are the main benefits of the 3-month depot formulation?
A: The 3-month depot formulation reduces the number of injections required, thereby increasing patient convenience and compliance. It also helps maintain consistent therapeutic hormone levels, which is crucial in managing hormone-sensitive conditions.